Flywire Corporation (FLYW) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before September 23, 2025

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / If you suffered a loss on your Flywire Corporation (NASDAQ:FLYW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/flywire-corporation-lawsuit-submission-form?prid=165334&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

The RealReal’s 2025 Resale Report

(NASDAQ:REAL), The Economics of Resale, From Investment Jewelry to Nostalgic Comebacks SAN FRANCISCO, Sept. 04, 2025 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL) – the world's largest online marketplace for authenticated resale luxury goods – today released its annual Resale Report. For the past 14 years, The RealReal has been at the forefront of a

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen

-New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC) who were given a continuous regimen of 120-days of valacyclovir and celecoxib with a pulsed 15-day treatment of Paxlovid (combination antiviral treatment, or CAR), and these patients were compared to 12 patients with Long COVID

The RealReal’s 2025 Resale Report

The RealReal's 2025 Resale Report GlobeNewswire September 04, 2025 The Economics of Resale, From Investment Jewelry to Nostalgic Comebacks SAN FRANCISCO, Sept. 04, 2025 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL) – the world's largest online marketplace for authenticated resale luxury goods – today released its annual Resale Report. For the past 14 years, The

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen GlobeNewswire September 04, 2025 -New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC) who were given a continuous regimen of 120-days of valacyclovir and celecoxib with a pulsed 15-day treatment of Paxlovid

Calgary drives the future of energy with strategic investment into ETC Foundation

TheOpportunity Calgary Investment Fund (OCIF), along with PrairiesCan, Alberta Innovates, CIBC, Avatar Innovations, and Pathways Alliance are investing in a project valued at over $10 million into the ETC Foundation, reinforcing Calgary's position as the energy capital of Canada and leader in energy innovation. This investment into the ETC Foundation includes a significant expansion of

New Real-World Study Seeking 500 Participants for At-Home Focus, Energy, and Mood Studies

The Network of Applied Pharmacognosy (NAP) and MoreBetter are building on findings from previous real-world studies on various dietary supplement formulas, and their reported benefit for clarity, focus, and energy. Eligible adults will receive a free 2-3 week product supply from the study sponsor. The study sponsor is disclosed to study participants upon confirmed eligibility

Stagwell (STGW) Appoints Slavi Samardzija as Chief Data and Platforms Officer to Drive Cutting-Edge, Holistic Data Strategy

Stagwell(NASDAQ: STGW), the challenger network built to transform marketing, announced the appointment of Slavi Samardzija as Chief Data and Platforms Officer at Stagwell, effective today. In this newly created role, Samardzija will lead the development and execution of a forward-looking data and platform strategy as Stagwell implements its ID Graph and The Machine. Samardzija brings

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lockheed Martin Corporation of Class Action Lawsuit and Upcoming Deadlines – LMT

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Lockheed Martin Corporation ("Lockheed" or the "Company") (NYSE:LMT).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Vanguard Appoints Natalie Lamarque as Chief Legal Officer

Vanguard today announced that Natalie Lamarque will join the firm as Chief Legal Officer. She will be responsible for all legal and compliance activities, public policy, and investment stewardship. She will also serve as managing director of Vanguard's legal division, secretary of the Vanguard Board of Directors, and secretary of the Vanguard funds. https://mma.prnewswire.com/media/1221288/Vanguard_Logo.jpg “Natalie

Scroll to Top